Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kyriaki Boki"'
Autor:
Maria Tektonidou, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis, Prodromos Sidiropoulos, Petros P Sfikakis, Antigone Pieta, Dimitrios Vassilopoulos, Maria Pappa, Paraskevi V Voulgari, Theodoros Dimitroulas, Andreas Goules, Charalampos Papagoras, Christina Tsalapaki, Maria Kosmetatou, Flora Chouzouri, Evangelia Argyriou, Aglaia Chalkia, Mirto Cheila, Georgios Demirtzoglou, Christina Katsiari, Dimitrios Petras, Kyriaki Boki
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/692ef3146c6444f8991a42f0240eb682
Autor:
Konstantinos Thomas, Evangelia Argyriou, Noemin Kapsala, Alexandros Panagiotopoulos, Aglaia Chalkia, Emilia Hadziyannis, Kyriaki Boki, Pelagia Katsimbri, Dimitrios T. Boumpas, Panagiota Giannou, Dimitrios Petras, Dimitrios Vassilopoulos
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-9 (2021)
Abstract Background Serious infections (SI) are common in patients with ANCA-associated vasculitides (AAV) like granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Real-life data regarding their incidence and predisposing facto
Externí odkaz:
https://doaj.org/article/e99a3cf6f8334f06b99857d737b91364
Autor:
Irini Genitsaridi, Irini Flouri, Dimitris Plexousakis, Konstantinos Marias, Kyriaki Boki, Fotini Skopouli, Alexandros Drosos, George Bertsias, Dimitrios Boumpas, Prodromos Sidiropoulos
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background The long-term outcome of rheumatoid arthritis (RA) patients who in clinical practice exhibit persistent moderate disease activity (pMDA) despite treatment with biologics has not been adequately studied. Herein, we analyzed the 5-y
Externí odkaz:
https://doaj.org/article/ce08e7f0d0ea43319881472ea1cc3098
Autor:
Antonis Fanouriakis, Maria Tektonidou, George Bertsias, Dimitrios Boumpas, Petros Sfikakis, Prodromos Sidiropoulos, Dimitrios Vassilopoulos, Alexandros Garyfallos, Charalampos Papagoras, Pinelopi Konstantopoulou, Kyriaki Boki, Antonia Elezoglou, Maria Kosmetatou, Maria Pappa
Publikováno v:
Mediterranean journal of rheumatology. 33(2)
Lupus nephritis (LN) affects a significant proportion of patients with systemic lupus erythematosus (SLE) and is characterised by increased morbidity and mortality. The updated joint EULAR/European Renal Association-European Dialysis and Transplant A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630ea658705c928cdb354faf04e2938a
https://pubmed.ncbi.nlm.nih.gov/36128201
https://pubmed.ncbi.nlm.nih.gov/36128201
Autor:
Styliani Ntali, Dionysis Nikolopoulos, Lamprini Pantazi, Evgenia Emmanouilidou, Charalampos Papagoras, Antonis Fanouriakis, Despoina Dimopoulou, Ioannis Kallitsakis, Kyriaki Boki, Vicky Dania, Prodromos I. Sidiropoulos, Dimitrios T. Boumpas, George Bertsias
Publikováno v:
Clinical and experimental rheumatology. 40(9)
Systemic lupus erythematosus (SLE) patients show variably increased risk for pregnancy complications. We analysed pregnancy outcomes (foetal and maternal), patterns of disease activity and use of medications in a contemporary Caucasian SLE population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1473e81d8e3482e9236321ef4102b5dd
https://pubmed.ncbi.nlm.nih.gov/35084312
https://pubmed.ncbi.nlm.nih.gov/35084312
Autor:
Sophie, Mavrogeni, George D, Kitas, Hildo J, Lamb, Klearchos, Psychogios, Theodoros, Dimitroulas, Loukia, Koutsogeorgopoulou, Kyriaki, Boki, Vasiliki, Vartela, Genovefa, Kolovou, George, Markousis-Mavrogenis, Cees G, Kallenberg, Loic, Guillevin, Dimitrios, Vassilopoulos
Publikováno v:
Clinical and experimental rheumatology. 36(2)
Systemic vasculitides (SVs) is a group of diseases characterised by inflammation/necrosis of the blood vessel wall in various organs. Simultaneous brain and heart involvement is a cause of increased morbidity/mortality in SV. We aimed to present evid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2135a6212572022c0455cdd3a9a3e4d
https://pubmed.ncbi.nlm.nih.gov/29652661
https://pubmed.ncbi.nlm.nih.gov/29652661
Autor:
Nadia, Boubouchairopoulou, Irini, Flouri, Alexandros A, Drosos, Kyriaki, Boki, Loukas, Settas, Dimitrios, Zisopoulos, Fotini N, Skopouli, Ioannis, Papadopoulos, Alexios, Iliopoulos, John, Kyriopoulos, Dimitrios T, Boumpas, Konstantinos, Athanasakis, Prodromos, Sidiropoulos
Publikováno v:
Clinical and experimental rheumatology. 34(6)
To assess in daily practice in patients with rheumatoid arthritis (RA) the effect of treatment with first tumour necrosis factor-α inhibitor (TNFi) in quality of life (Qol), disease activity and depict possible baseline predictors for gains in Qol.P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94f8c4d9002885e8719b91d536bef797
https://pubmed.ncbi.nlm.nih.gov/27749220
https://pubmed.ncbi.nlm.nih.gov/27749220
Autor:
Dimitrios, Vassilopoulos, Evie M, Delicha, Loukas, Settas, Alexandros, Andrianakos, Spyros, Aslanidis, Panagiota, Boura, Marios, Katsounaros, Panagiotis, Athanassiou, Konstantinos, Tempos, Grigorios, Skarantavos, Christodoulos, Antoniadis, Sotirios, Papazoglou, Lazaros, Sakkas, Vassiliki, Galanopoulou, Fotini, Skopouli, Kyriaki, Boki, Dimitrios, Daoussis, Eleni, Vritzali, Petros P, Sfikakis
Publikováno v:
Clinical and experimental rheumatology. 34(5)
To evaluate the long-term safety of rituximab (RTX) in rheumatoid arthritis (RA) patients in daily clinical practice.This was a multicentre (17 Greek Rheumatology sites), prospective, long-term, pharmacovigilance study of patients with moderate to se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21e2524038fe001a35f6c5291b89bce4
https://pubmed.ncbi.nlm.nih.gov/27383049
https://pubmed.ncbi.nlm.nih.gov/27383049
Autor:
Garifallia, Linardaki, Olga, Katsarou, Panagiota, Ioannidou, Anastasia, Karafoulidou, Kyriaki, Boki
Publikováno v:
The Journal of rheumatology. 34(6)
High levels of tumor necrosis factor-alpha (TNF-alpha) are associated with hepatitis C virus (HCV) infection and all stages of human immunodeficiency virus (HIV) infection. TNF-alpha may have a role in both the pathogenesis and the response to treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f554c30bdb99aa17d8cd6c4467664887
https://pubmed.ncbi.nlm.nih.gov/17552060
https://pubmed.ncbi.nlm.nih.gov/17552060
Publikováno v:
Mayo Clinic Proceedings. 76:111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc933c7e461aad6f1dc2f5876d292e97
https://doi.org/10.4065/76.1.111
https://doi.org/10.4065/76.1.111